Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs propofol effects on basal ganglia activity in Parkinson's disease with deep brain stimulators
2014-000868-17Phase 4Completed
- Sponsor
- Clínica Universidad de Navarra
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and propofol in Parkinson's disease (PD) (2 arms), sponsored by Clínica Universidad de Navarra. Primary endpoint: Basal ganglia local field potential signal power. Started Mar 2014; status: completed.
02
Drugs
dexmedetomidinepropofol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2014-000868-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000868-17.